Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a warning letter to Hawaii Pharm LLC on April 24, 2020, regarding dietary supplement products. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata alone. The warning falls under FDA's dietary supplement regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues cited, review of the complete warning letter would be necessary.